{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:12:03Z","timestamp":1793394723135,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:p>This study investigates the epidemiological trends of malignant neoplasms of bone and articular cartilage (MNBAC) in China from 1992 to 2021, examines their association with age-period-cohort factors, and forecasts the future epidemiological trends of MNBAC for the period 2022 to 2031. Data on the incidence, prevalence, mortality, and disability-adjusted life years associated with MNBAC were sourced from the Global Burden of Disease 2021 database. Temporal trends were analyzed through age-standardized rates (ASR) and estimated annual percentage changes to capture variations over time. An age-period-cohort analysis was performed to evaluate the impact of demographic and temporal factors. Additionally, future trends for 2022 to 2031 were forecasted using the auto-regressive integrated moving average modeling approach. From 1992 to 2021, the incidence, prevalence, mortality, and disability-adjusted life years rates of MNBAC in China showed a consistent overall increase, despite a downward trend in ASR. As of 2021, the age-standardized incidence rate was recorded at 1.4 per 100,000 (95% uncertainty intervals: 0.9\u20131.9), with an estimated annual percentage changes of 3.27 (95% confidence intervals: 2.57\u20133.98). Males exhibited markedly higher rates across all metrics compared to females. The disease burden followed a bimodal age distribution, disproportionately affecting adolescents and older adults. Projections for 2022 to 2031 indicate declines in age-standardized metrics but an absolute increase in case numbers, primarily attributed to population growth and aging demographics. This analysis underscores the growing burden of MNBAC in China, marked by higher rates in males and a bimodal age distribution affecting adolescents and the elderly. While ASR are anticipated to decline in the coming decade, the overall disease burden is likely to rise persistently. These findings provide valuable insights into the epidemiological trends and determinants of MNBAC, forming a basis for targeted interventions and future research priorities.<\/jats:p>","DOI":"10.1097\/md.0000000000046472","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:03:28Z","timestamp":1766203408000},"page":"e46472","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Burden analysis of malignant neoplasms of bone and articular cartilage in China: Epidemiological trends and future projections based on the global burden of disease study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2780-3433","authenticated-orcid":false,"given":"Le","family":"Ma","sequence":"first","affiliation":[{"name":"Guangdong Institute of Orthopedics and Trauma of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China"},{"name":"Department of Orthopedics, The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuke","family":"Song","sequence":"additional","affiliation":[{"name":"Guangdong Institute of Orthopedics and Trauma of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China"},{"name":"Department of Orthopedics, The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong Institute of Orthopedics and Trauma of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China"},{"name":"Department of Orthopedics, The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/os.12851","article-title":"Homogenous and heterogenous prognostic factors for patients with bone sarcoma.","volume":"13","author":"Xu","year":"2021","journal-title":"Orthop Surg"},{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PAP.0000000000000293","article-title":"The 2020 WHO classification of tumors of bone: an updated review.","volume":"28","author":"Choi","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.34694","article-title":"Twenty-year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors.","volume":"154","author":"Xu","year":"2024","journal-title":"Int J Cancer"},{"key":"R4-20260522","first-page":"205","article-title":"Bone cancer: diagnosis and treatment principles.","volume":"98","author":"Ferguson","year":"2018","journal-title":"Am Fam Physician"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1097\/CM9.0000000000002547","article-title":"Primary malignant bone tumors incidence, mortality, and trends in China from 2000 to 2015.","volume":"136","author":"Xi","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age-period-cohort analysis of cancer incidence and mortality rates.","volume":"23","author":"Rosenberg","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40122-022-00422-9","article-title":"Time trends in the incidence of spinal pain in China, 1990 to 2019 and its prediction to 2030: the global burden of disease study 2019.","volume":"11","author":"Wei","year":"2022","journal-title":"Pain Ther"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"1008598","DOI":"10.3389\/fpubh.2022.1008598","article-title":"Trend dynamics of gout prevalence among the Chinese population, 1990","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Public Health"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"1419428","DOI":"10.3389\/fpubh.2024.1419428","article-title":"Disease burden and attributable risk factors of lip and oral cavity cancer in China from 1990 to 2021 and its prediction to 2031.","volume":"12","author":"Yu","year":"2024","journal-title":"Front Public Health"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.","volume":"16","author":"Li","year":"2023","journal-title":"Clin Kidney J"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"117212","DOI":"10.1016\/j.bone.2024.117212","article-title":"Global, regional, and national burden and trends analysis of malignant neoplasm of bone and articular cartilage from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"188","author":"Lai","year":"2024","journal-title":"Bone"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BCO.0000000000000405","article-title":"Global incidence of primary malignant bone tumors.","volume":"27","author":"Kumar","year":"2016","journal-title":"Curr Orthop Pract"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/cncr.34163","article-title":"Osteosarcoma: a surveillance, epidemiology, and end results program-based analysis from 1975 to 2017.","volume":"128","author":"Cole","year":"2022","journal-title":"Cancer"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"837506","DOI":"10.3389\/fpubh.2022.837506","article-title":"A nomogram for predicting cancer-specific survival of osteosarcoma and Ewing\u2019s sarcoma in children: a SEER database analysis.","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"issue":"Suppl 4","key":"R18-20260522","doi-asserted-by":"crossref","first-page":"iv79","DOI":"10.1093\/annonc\/mdy310","article-title":"Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcancer.2023.07.003","article-title":"Artificial intelligence-based radiomics in bone tumors: technical advances and clinical application.","volume":"95","author":"Meng","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11914-023-00803-9","article-title":"Advances in osteosarcoma.","volume":"21","author":"Panez-Toro","year":"2023","journal-title":"Curr Osteoporos Rep"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"e002086","DOI":"10.1136\/bmjgh-2019-002086","article-title":"Towards universal health coverage: lessons from 10 years of healthcare reform in China.","volume":"5","author":"Tao","year":"2020","journal-title":"BMJ Glob Health"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5582\/bst.2018.01265","article-title":"China issues the National Essential Medicines List (2018 edition): Background, differences from previous editions, and potential issues.","volume":"12","author":"He","year":"2018","journal-title":"Biosci Trends"},{"key":"R24-20260522","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(19)32136-1","article-title":"10 years of health-care reform in China: progress and gaps in Universal Health Coverage.","volume":"394","author":"Yip","year":"2019","journal-title":"Lancet"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003\u201315: a pooled analysis of 17 population-based cancer registries.","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R26-20260522","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(14)70029-4","article-title":"Challenges to effective cancer control in China, India, and Russia.","volume":"15","author":"Goss","year":"2014","journal-title":"Lancet Oncol"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.3390\/curroncol30080555","article-title":"Cost drivers and financial burden for cancer-affected families in China: a systematic review.","volume":"30","author":"Jia","year":"2023","journal-title":"Curr Oncol"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"994034","DOI":"10.3389\/fimmu.2022.994034","article-title":"Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"R29-20260522","doi-asserted-by":"crossref","first-page":"997765","DOI":"10.3389\/fimmu.2022.997765","article-title":"Identification and characterization of aging\/senescence-induced genes in osteosarcoma and predicting clinical prognosis.","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20260522","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13075-023-03205-5","article-title":"Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional Mendelian randomization study.","volume":"25","author":"Yang","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"R31-20260522","first-page":"153","article-title":"Secondary osteosarcoma in patients previously treated for childhood cancer: three case reports.","volume":"10","author":"Shimatani","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"R32-20260522","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jso.22122","article-title":"Post-radiation sarcomas. Clinical outcome of 52 Patients.","volume":"105","author":"Mavrogenis","year":"2012","journal-title":"J Surg Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:03:14Z","timestamp":1779433394000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":30,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046472","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-08-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}